China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.564
-0.024 (-4.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed

China Pharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
23644523
Upgrade
Market Cap Growth
407.79%35.75%12.27%-19.49%-78.32%17.59%
Upgrade
Enterprise Value
269881330
Upgrade
Last Close Price
0.561.212.336.0547.95241.30
Upgrade
PS Ratio
5.511.470.990.570.612.37
Upgrade
PB Ratio
0.380.270.580.541.153.80
Upgrade
P/TBV Ratio
--4.250.952.003.89
Upgrade
P/FCF Ratio
256.9368.33----
Upgrade
P/OCF Ratio
154.1240.99----
Upgrade
EV/Sales Ratio
6.372.261.721.141.603.10
Upgrade
EV/EBITDA Ratio
---4370.46-131.65
Upgrade
EV/FCF Ratio
296.75105.43----
Upgrade
Debt / Equity Ratio
0.170.170.480.622.042.08
Upgrade
Debt / EBITDA Ratio
---58.59-39.10
Upgrade
Debt / FCF Ratio
43.7143.71----
Upgrade
Net Debt / Equity Ratio
0.160.160.400.431.571.27
Upgrade
Net Debt / EBITDA Ratio
-2.24-2.24-1.581751.33-7.9333.56
Upgrade
Net Debt / FCF Ratio
39.8339.83-7.02-4.51-8.29-11.09
Upgrade
Asset Turnover
0.180.180.290.410.400.44
Upgrade
Inventory Turnover
2.192.192.172.052.552.64
Upgrade
Quick Ratio
0.090.090.180.310.200.53
Upgrade
Current Ratio
0.320.320.650.880.470.87
Upgrade
Return on Equity (ROE)
-20.91%-20.91%-62.31%-52.43%-77.08%-48.49%
Upgrade
Return on Assets (ROA)
-8.41%-8.41%-18.29%-10.04%-10.97%-8.17%
Upgrade
Return on Capital Employed (ROCE)
-13.10%-13.10%-46.50%-28.50%-70.40%-23.60%
Upgrade
Earnings Yield
-13.95%-52.46%-105.81%-77.22%-80.22%-14.88%
Upgrade
FCF Yield
0.39%1.46%-9.93%-17.84%-16.39%-3.01%
Upgrade
Buyback Yield / Dilution
-145.73%-145.73%-416.13%-221.82%-13.96%-5.75%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.